Literature DB >> 18464287

CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.

Paula V Nunes1, Breno S Diniz, Marcia Radanovic, Izabella D Abreu, Danilo T Borelli, Monica S Yassuda, Orestes V Forlenza.   

Abstract

BACKGROUND: The CAMCOG is a brief neuropsychological battery designed to assess global cognitive function and ascertain the impairments that are required for the diagnosis of dementia. To date, the cut-off scores for mild cognitive impairment (MCI) have not been determined. Given the need for an earlier diagnosis of mild dementia, new cut-off values are also necessary, taking into account cultural and educational effects.
METHODS: One hundred and fifty-seven older adults (mean age: 69.6 +/- 7.4 years) with 8 or more years of formal education (mean years of schooling 14.2 +/- 3.8) attending a memory clinic at the Institute of Psychiatry University of Sao Paulo were included. Subjects were divided into three groups according to their cognitive status, established through clinical and neuropsychological assessment: normal controls, n = 62; MCI, n = 65; and mild or moderate dementia, n = 30. ROC curve analyses were performed for dementia vs controls, MCI vs controls and MCI vs dementia.
RESULTS: The cut-off values were: 92/93 for dementia vs controls (AUC = 0.99: sensitivity: 100%, specificity: 95%); 95/96 for MCI vs controls (AUC = 0.83, sensitivity: 64%, specificity: 88%), and 85/86 for MCI vs dementia (AUC = 0.91, sensitivity: 81%, specificity: 88%). The total CAMCOG score was more accurate than its subtests Mini-mental State Examination, Verbal Fluency Test and Clock Drawing Test when used separately.
CONCLUSIONS: The CAMCOG discriminated controls and MCI from demented patients, but was less accurate to discriminate MCI from controls. The best cut-off value to differentiate controls and demented was higher than suggested in the original publication, probably because only cases of mild to moderate dementia were included. This is important given the need for a diagnostic at earlier stages of Alzheimer's disease. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18464287     DOI: 10.1002/gps.2038

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  13 in total

1.  Spectral analyses of systolic blood pressure and heart rate variability and their association with cognitive performance in elderly hypertensive subjects.

Authors:  W B Santos; J M D Matoso; M Maltez; T Gonçalves; M Casanova; I F H Moreira; R A Lourenço; W D Monteiro; P T V Farinatti; P P Soares; W Oigman; M F T Neves; M L G Correia
Journal:  J Hum Hypertens       Date:  2014-12-18       Impact factor: 3.012

Review 2.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

3.  Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.

Authors:  Rodolfo B Ladeira; Breno S Diniz; Paula V Nunes; Orestes V Forlenza
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

4.  Feasibility and validity of dementia assessment by trained community health workers based on Clinical Dementia Rating.

Authors:  Hae-Ra Han; So-Youn Park; Heejung Song; Miyong Kim; Kim B Kim; Hochang Ben Lee
Journal:  J Am Geriatr Soc       Date:  2013-06-03       Impact factor: 5.562

5.  Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.

Authors:  Wagner F Gattaz; Leda L Talib; Evelin L Schaeffer; Breno S Diniz; Orestes V Forlenza
Journal:  J Neural Transm (Vienna)       Date:  2013-09-15       Impact factor: 3.575

6.  Application study of quick cognitive screening test in identifying mild cognitive impairment.

Authors:  Qi-Hao Guo; Xin-Yi Cao; Yan Zhou; Qian-Hua Zhao; Ding Ding; Zhen Hong
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

7.  Internet-based screening for dementia risk.

Authors:  Jason Brandt; Campbell Sullivan; Larry E Burrell; Mark Rogerson; Allan Anderson
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

8.  Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?

Authors:  José Eduardo Martinelli; Juliana Francisca Cecato; Daniel Bartholomeu; José Maria Montiel
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-05-20

9.  A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints.

Authors:  Fábio Henrique de Gobbi Porto; Lívia Spíndola; Maira Okada de Oliveira; Patrícia Helena Figuerêdo do Vale; Marco Orsini; Ricardo Nitrini; Sonia Maria Dozzi Brucki
Journal:  Neurol Int       Date:  2013-09-05

10.  Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil.

Authors:  Analucy Aury Vieira de Oliveira; Corina Satler; Carlos Tomaz
Journal:  Dement Neuropsychol       Date:  2012 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.